Compact point-of-care system for clinical diagnostics
暂无分享,去创建一个
Albrecht Brandenburg | Gerd Sulz | Ursula Sauer | Claudia Preininger | Birgit Koger | Manuel Kemmler | E. Schleicher | G. Sulz | A. Brandenburg | Erwin Schleicher | C. Preininger | Manuel Kemmler | U. Sauer | Birgit Koger | B. Koger
[1] P. Zabel,et al. Procalcitonin as a marker of severity in septic shock , 1999, Langenbeck's Archives of Surgery.
[2] G J Kost,et al. The laboratory-clinical interface: point-of-care testing. , 1999, Chest.
[3] Wolfgang Budach,et al. Planar Waveguides as High-Performance Sensing Platforms for Fluorescence-Based Multiplexed Oligonucleotide Hybridization Assays , 1999 .
[4] A. Antinori,et al. Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis , 2001, European Journal of Pediatrics.
[5] N. Thompson,et al. Total internal reflection fluorescence. , 1984, Annual review of biophysics and bioengineering.
[6] Elisabeth Kremmer,et al. Development and characterization of new rat monoclonal antibodies for procalcitonin , 2008, Analytical and bioanalytical chemistry.
[7] Frances S. Ligler,et al. An Array Immunosensor for Simultaneous Detection of Clinical Analytes , 1999 .
[8] Uwe Pieles,et al. Novel bioaffinity sensors for trace analysis based on luminescence excitation by planar waveguides , 1997 .
[9] John W. A. Findlay,et al. Appropriate calibration curve fitting in ligand binding assays , 2007, The AAPS Journal.
[10] C. Sprung,et al. Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.
[11] M. Kaul,et al. IL-6 as a Marker of Excessive TNF-α Activity in Sepsis , 1999 .
[12] J. Inczedy,et al. Compendium of Analytical Nomenclature , 1998 .
[13] Levente Bodrossy,et al. ARChip epoxy and ARChip UV for covalent on-chip immobilization of pmoA gene-specific oligonucleotides. , 2004, Analytical biochemistry.
[14] G. Clermont,et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.
[15] F. Brunkhorst,et al. Aktuelle Aspekte zur Sepsisdiagnose , 2002 .
[16] Mark B Pepys,et al. C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.
[17] F. Budak,et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[18] R. Wenzel,et al. Severe sepsis-national estimates. , 2001, Critical care medicine.
[19] E. Moore,et al. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? , 1996, Annals of surgery.
[20] Irving Kushner,et al. C-reactive Protein* , 2004, Journal of Biological Chemistry.
[21] K. Reinhart,et al. [Diagnostic approach to sepsis - state of the art]. , 2002, Zentralblatt fur Chirurgie.
[22] Yasar Gurbuz,et al. Sandwich-type, antibody microarrays for the detection and quantification of cardiovascular risk markers , 2007 .
[23] G. Sulz,et al. Real-time detection of nucleic acid interactions by total internal reflection fluorescence. , 2003, Analytical chemistry.
[24] M. A. Bopp,et al. Zeptosens' protein microarrays: A novel high performance microarray platform for low abundance protein analysis , 2002, Proteomics.
[25] A. Turygin,et al. Development of a biochip with an internal calibration curve for quantitating two forms of the prostate-specific antigen , 2007, Molecular Biology.